AbbVie: a pharma giant navigating its defining transition (ABBV)

From The Gemini Brief - Investment Deep Dives · 00:52:03

Show by Lukasz Tomicki and LRT Capital Management LLC

Slide Deck AbbVie has executed what may be the most successful franchise replacement in pharmaceutical history. The company’s combined Skyrizi and Rinvoq revenues reached $25.9 billion in 2025 — surpassing Humira’s all-time peak of $21.2 billion — while Humira itself declined to $4.5 billion from that peak. Total revenue hit a record $61.2 billion in […]

More episodes of The Gemini Brief - Investment Deep Dives

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.